Finance

Lists
Why is QNTM down 5,22%?
Dive Deeper
QNTM:NASDAQ
Quantum Biopharma Ltd
3,27 US$
-5,22%
(-0,18) 1D
3,31 US$
+1,15% (+0,037)
After hours
Closed: 5 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QNTM...
Open
3,40 US$
High
3,49 US$
Low
3,25 US$
Mkt. cap
26,91 მლნ.
Avg. vol.
173,12 ათ.
Volume
246,76 ათ.
52-wk high
18,87 US$
52-wk low
2,07 US$
EPS
-5,70 US$
Beta
0,39
Shares outstanding
8,09 მლნ.
No. of employees
17
Open
3,40 US$
High
3,49 US$
Low
3,25 US$
Mkt. cap
26,91 მლნ.
Avg. vol.
173,12 ათ.
Volume
246,76 ათ.
52-wk high
18,87 US$
52-wk low
2,07 US$
EPS
-5,70 US$
Beta
0,39
Shares outstanding
8,09 მლნ.
No. of employees
17
News stories
From web sources and news partners
About Quantum Biopharma Ltd
CEO-
Employees17
Founded1994
Headquarters-
SectorPharmaceutical industry
Websitequantumbiopharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to QNTM in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for QNTM in the last 3 months
Highest
Current 3,27 US$
8,00 US$ (+144,65%)
Average
8,00 US$ (+144,65%)
Lowest
8,00 US$ (+144,65%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael King
Rodman & Renshaw
Buy
Initiated
8,00 US$
+144,6%
08/31/2026
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
495,22 ათ.
70,40 ათ.
626,09 ათ.
387,43 ათ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,04 მლნ.
1,37 მლნ.
1,32 მლნ.
1,76 მლნ.
Operating expense
4,68 მლნ.
2,37 მლნ.
2,97 მლნ.
2,29 მლნ.
Total operating expenses
4,68 მლნ.
2,37 მლნ.
2,97 მლნ.
2,29 მლნ.
Operating income
-4,68 მლნ.
-2,37 მლნ.
-2,97 მლნ.
-2,29 მლნ.
Other non operating income
-222,38 ათ.
-2,48 მლნ.
-10,47 მლნ.
-972,01 ათ.
EBT including unusual items
-4,75 მლნ.
-3,70 მლნ.
-13,75 მლნ.
-3,09 მლნ.
EBT excluding unusual items
-4,91 მლნ.
-6,29 მლნ.
-13,48 მლნ.
-3,50 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5,32 მლნ.
-3,03 მლნ.
-13,56 მლნ.
-3,25 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
100,42 ათ.
-
-
-
Interest expense
-105,08 ათ.
-1,44 მლნ.
-45,18 ათ.
-239,16 ათ.
Net interest expenses
-4,66 ათ.
-1,44 მლნ.
-45,18 ათ.
-239,16 ათ.
Depreciation and amortization charges
145,34 ათ.
129,37 ათ.
127,44 ათ.
128,37 ათ.
EBITDA
-4,53 მლნ.
-2,24 მლნ.
-2,84 მლნ.
-2,17 მლნ.
Gain or loss from assets sale
-
117,14 ათ.
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები